Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net loss $ (38,301)us-gaap_NetIncomeLoss $ (124,058)us-gaap_NetIncomeLoss $ (71,065)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 1,856us-gaap_Depreciation 2,575us-gaap_Depreciation 4,124us-gaap_Depreciation
Common stock contribution to 401(k) 870us-gaap_NoncashContributionExpense 828us-gaap_NoncashContributionExpense 1,134us-gaap_NoncashContributionExpense
Stock-based compensation expense 10,772us-gaap_ShareBasedCompensation 5,099us-gaap_ShareBasedCompensation 4,284us-gaap_ShareBasedCompensation
Accrued interest on interest bearing obligations (1,444)us-gaap_DebtInstrumentIncreaseAccruedInterest 2,284us-gaap_DebtInstrumentIncreaseAccruedInterest 1,186us-gaap_DebtInstrumentIncreaseAccruedInterest
Revaluation of contingent warrant liabilities (45,773)xoma_UnrealizedGainLossOnWarrants 61,039xoma_UnrealizedGainLossOnWarrants 9,172xoma_UnrealizedGainLossOnWarrants
Restructuring charge related to long-lived assets 0us-gaap_AssetImpairmentCharges 0us-gaap_AssetImpairmentCharges 2,460us-gaap_AssetImpairmentCharges
Amortization of debt discount, final payment fee on debt, and debt issuance costs 2,707us-gaap_AmortizationOfFinancingCostsAndDiscounts 2,470us-gaap_AmortizationOfFinancingCostsAndDiscounts 1,958us-gaap_AmortizationOfFinancingCostsAndDiscounts
Loss on sale and retirement of property and equipment 0us-gaap_GainLossOnDispositionOfAssets 281us-gaap_GainLossOnDispositionOfAssets 29us-gaap_GainLossOnDispositionOfAssets
Unrealized loss on foreign currency exchange (2,280)us-gaap_ForeignCurrencyTransactionGainLossUnrealized 662us-gaap_ForeignCurrencyTransactionGainLossUnrealized 295us-gaap_ForeignCurrencyTransactionGainLossUnrealized
Unrealized loss on foreign exchange options 355us-gaap_UnrealizedGainLossOnDerivatives 127us-gaap_UnrealizedGainLossOnDerivatives 714us-gaap_UnrealizedGainLossOnDerivatives
Other non-cash adjustments (9)us-gaap_OtherNoncashIncomeExpense (20)us-gaap_OtherNoncashIncomeExpense (11)us-gaap_OtherNoncashIncomeExpense
Changes in assets and liabilities:      
Trade and other receivables, net 472us-gaap_IncreaseDecreaseInReceivables 4,486us-gaap_IncreaseDecreaseInReceivables 4,064us-gaap_IncreaseDecreaseInReceivables
Prepaid expenses and other assets (662)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 481us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (158)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable and accrued liabilities (3,774)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 2,901us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 4,485us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Deferred revenue (2,983)us-gaap_IncreaseDecreaseInDeferredRevenue (3,399)us-gaap_IncreaseDecreaseInDeferredRevenue (3,511)us-gaap_IncreaseDecreaseInDeferredRevenue
Other liabilities (88)us-gaap_IncreaseDecreaseInOtherOperatingLiabilities (1,671)us-gaap_IncreaseDecreaseInOtherOperatingLiabilities 75us-gaap_IncreaseDecreaseInOtherOperatingLiabilities
Net cash used in operating activities (78,282)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (45,915)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (40,765)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:      
Purchases of investments 0us-gaap_PaymentsToAcquireShortTermInvestments (19,991)us-gaap_PaymentsToAcquireShortTermInvestments (56,970)us-gaap_PaymentsToAcquireShortTermInvestments
Proceeds from maturities of investments 20,000us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments 40,000us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments 17,000us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
Purchase of property and equipment (325)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (1,169)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (2,509)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of property and equipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 463us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
Net cash provided by (used in) investing activities 19,675us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations 18,840us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (42,016)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:      
Proceeds from issuance of common stock, net of issuance costs 41,442us-gaap_ProceedsFromIssuanceOfCommonStock 84,338us-gaap_ProceedsFromIssuanceOfCommonStock 76,498us-gaap_ProceedsFromIssuanceOfCommonStock
Proceeds from the exercise of warrants 35us-gaap_ProceedsFromWarrantExercises 2,176us-gaap_ProceedsFromWarrantExercises 993us-gaap_ProceedsFromWarrantExercises
Proceeds from issuance of long-term debt, net of issuance costs 0us-gaap_ProceedsFromIssuanceOfLongTermDebt 0us-gaap_ProceedsFromIssuanceOfLongTermDebt 4,434us-gaap_ProceedsFromIssuanceOfLongTermDebt
Principal payments of debt (5,917)us-gaap_RepaymentsOfLongTermDebt (3,125)us-gaap_RepaymentsOfLongTermDebt (2,143)us-gaap_RepaymentsOfLongTermDebt
Net cash provided financing activities 35,560us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 83,389us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 79,782us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Effect of exchange rate changes on cash (167)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 0us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 0us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net (decrease) increase in cash and cash equivalents (23,214)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 56,314us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (2,999)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at the beginning of the period 101,659us-gaap_CashAndCashEquivalentsAtCarryingValue 45,345us-gaap_CashAndCashEquivalentsAtCarryingValue 48,344us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at the end of the period 78,445us-gaap_CashAndCashEquivalentsAtCarryingValue 101,659us-gaap_CashAndCashEquivalentsAtCarryingValue 45,345us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash paid during the year for:      
Interest 3,009us-gaap_InterestPaid 1,262us-gaap_InterestPaid 1,035us-gaap_InterestPaid
Non-cash investing and financing activities:      
Issuance of warrants 10,258xoma_IssuanceOfWarrantLiabilities 0xoma_IssuanceOfWarrantLiabilities 6,390xoma_IssuanceOfWarrantLiabilities
Reclassification of contingent warrant liability to equity upon exercise of warrants (2,526)xoma_ReclassificationOfContingentWarrantLiabilityToEquityExerciseOfWarrants (6,171)xoma_ReclassificationOfContingentWarrantLiabilityToEquityExerciseOfWarrants (940)xoma_ReclassificationOfContingentWarrantLiabilityToEquityExerciseOfWarrants
Interest added to principal balances on long-term debt 313xoma_InterestAddedPrincipalBalancesLongTermDebt 935xoma_InterestAddedPrincipalBalancesLongTermDebt 1,160xoma_InterestAddedPrincipalBalancesLongTermDebt
Investment in Symplmed Pharmaceuticals, LLC 0us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 171us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 0us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
Discount on long-term debt $ 0xoma_DiscountOnLongTermDebt $ 0xoma_DiscountOnLongTermDebt $ (55)xoma_DiscountOnLongTermDebt